RxDoctor Payments Data

Ryan Bolotte, MD

Allergy & Immunology · Rockville, MDNPI 1497318018

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,518 of the $4,040 with a category attached, or 87.1%. It is spread thinly across 21 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,584, 4.0 times the $652 reported in 2023.

$4,040in general payments, 2019–2025

Across 139 payments — averaging $29.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$561
  • AstraZeneca$525
  • Takeda Pharmaceuticals U.S.A., Inc.$399
  • Grifols USA, LLC$388
  • Regeneron Healthcare Solutions, Inc.$342
  • Novartis$294
  • plus $2K from 15 others

What the payments were for

  • Consulting fees$221%
  • Grants$50012%
  • Food & beverage$3,51887%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,040 in reported general payments places this provider in the 60th percentile of 105 allergy & immunology providers in Maryland.

See all allergy & immunology providers in Maryland

Medicare billing

Part B allowed, 2024
$3,718
Medicare patients
17
Services billed
241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →